The following post rounds up the companies making headlines today:
Intel (INTC) reported upbeat second-quarter results on Tuesday after the market close. While it reported a loss due to a fine from the European Union, excluding that fine, Intel earned $1 billion, or 18 cents per share, topping estimates for earnings of 8 cents a share. Not only that, it also issued a positive second-half outlook. The results bolster the company's position that the computer business is on the mend after its roughest patch in years. Shares climbed about 7.5 percent ahead of the bell.
Abbott Labs (ABT) reported a 3 percent decline in second-quarter profit to $1.29 billion, or 83 cents per share. Excluding charges, earnings were 89 cents per share, inline with estimates. Blockbuster drug Humira continued gaining ground in the market. Shares declined about 1.5 percent in pre-market trade.